An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability

Ghislaine A. van Mastrigt; Silvia M. Evers; Marco Heerings; Leo H. Visser; Rob P. Ruimschotel; Astrid Hussaarts; Lotte Duyverman; Joyce Valkenburg-Vissers; Job Cornelissen; Michel Bos; Maarten van Droffelaar; Peter J. Jongen

doi:10.1080/13696998.2019.1609300

An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability

Ghislaine A. van Mastrigt^*, Silvia M. Evers, Marco Heerings, Leo H. Visser, Rob P. Ruimschotel, Astrid Hussaarts, Lotte Duyverman, Joyce Valkenburg-Vissers, Job Cornelissen, Michel Bos, Maarten van Droffelaar, Peter J. Jongen

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	0236-RT.R1/1609300
Pages (from-to)	967-980
Number of pages	14
Journal	Journal of Medical Economics
Volume	22
Issue number	10
DOIs	https://doi.org/10.1080/13696998.2019.1609300
Publication status	Published - 3 Oct 2019

Keywords

Relapsing remitting
multiple sclerosis
trial-based
economic evaluation
intense social cognitive theory-based treatment
self-efficacy
multidisciplinary
QUALITY-OF-LIFE
PREFERENCE-BASED MEASURE
SELF-EFFICACY
COST-EFFECTIVENESS
PHYSICAL-ACTIVITY
BEHAVIORAL THERAPY
UTILITY MEASURES
ADJUSTMENT GROUP
CLINICAL-TRIAL
HEALTH

Cite this

van Mastrigt, G. A., Evers, S. M., Heerings, M., Visser, L. H., Ruimschotel, R. P., Hussaarts, A., Duyverman, L., Valkenburg-Vissers, J., Cornelissen, J., Bos, M., van Droffelaar, M., & Jongen, P. J. (2019). An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability. Journal of Medical Economics, 22(10), 967-980. [0236-RT.R1/1609300]. https://doi.org/10.1080/13696998.2019.1609300

van Mastrigt, Ghislaine A. ; Evers, Silvia M. ; Heerings, Marco ; Visser, Leo H. ; Ruimschotel, Rob P. ; Hussaarts, Astrid ; Duyverman, Lotte ; Valkenburg-Vissers, Joyce ; Cornelissen, Job ; Bos, Michel ; van Droffelaar, Maarten ; Jongen, Peter J. / An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability. In: Journal of Medical Economics. 2019 ; Vol. 22, No. 10. pp. 967-980.

@article{c26715d8ff1948bc947fc289543156e7,

title = "An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability",

keywords = "Relapsing remitting, multiple sclerosis, trial-based, economic evaluation, intense social cognitive theory-based treatment, self-efficacy, multidisciplinary, QUALITY-OF-LIFE, PREFERENCE-BASED MEASURE, SELF-EFFICACY, COST-EFFECTIVENESS, PHYSICAL-ACTIVITY, BEHAVIORAL THERAPY, UTILITY MEASURES, ADJUSTMENT GROUP, CLINICAL-TRIAL, HEALTH",

author = "{van Mastrigt}, {Ghislaine A.} and Evers, {Silvia M.} and Marco Heerings and Visser, {Leo H.} and Ruimschotel, {Rob P.} and Astrid Hussaarts and Lotte Duyverman and Joyce Valkenburg-Vissers and Job Cornelissen and Michel Bos and {van Droffelaar}, Maarten and Jongen, {Peter J.}",

year = "2019",

month = oct,

day = "3",

doi = "10.1080/13696998.2019.1609300",

language = "English",

volume = "22",

pages = "967--980",

journal = "Journal of Medical Economics",

issn = "1369-6998",

publisher = "Routledge/Taylor & Francis Group",

number = "10",

}

van Mastrigt, GA , Evers, SM, Heerings, M, Visser, LH, Ruimschotel, RP, Hussaarts, A, Duyverman, L, Valkenburg-Vissers, J, Cornelissen, J, Bos, M, van Droffelaar, M & Jongen, PJ 2019, 'An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability', Journal of Medical Economics, vol. 22, no. 10, 0236-RT.R1/1609300, pp. 967-980. https://doi.org/10.1080/13696998.2019.1609300

An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability. / van Mastrigt, Ghislaine A.; Evers, Silvia M.; Heerings, Marco; Visser, Leo H.; Ruimschotel, Rob P.; Hussaarts, Astrid; Duyverman, Lotte; Valkenburg-Vissers, Joyce; Cornelissen, Job; Bos, Michel; van Droffelaar, Maarten; Jongen, Peter J.

In: Journal of Medical Economics, Vol. 22, No. 10, 0236-RT.R1/1609300, 03.10.2019, p. 967-980.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability

AU - van Mastrigt, Ghislaine A.

AU - Evers, Silvia M.

AU - Heerings, Marco

AU - Visser, Leo H.

AU - Ruimschotel, Rob P.

AU - Hussaarts, Astrid

AU - Duyverman, Lotte

AU - Valkenburg-Vissers, Joyce

AU - Cornelissen, Job

AU - Bos, Michel

AU - van Droffelaar, Maarten

AU - Jongen, Peter J.

PY - 2019/10/3

Y1 - 2019/10/3

KW - Relapsing remitting

KW - multiple sclerosis

KW - trial-based

KW - economic evaluation

KW - intense social cognitive theory-based treatment

KW - self-efficacy

KW - multidisciplinary

KW - QUALITY-OF-LIFE

KW - PREFERENCE-BASED MEASURE

KW - SELF-EFFICACY

KW - COST-EFFECTIVENESS

KW - PHYSICAL-ACTIVITY

KW - BEHAVIORAL THERAPY

KW - UTILITY MEASURES

KW - ADJUSTMENT GROUP

KW - CLINICAL-TRIAL

KW - HEALTH

U2 - 10.1080/13696998.2019.1609300

DO - 10.1080/13696998.2019.1609300

M3 - Article

VL - 22

SP - 967

EP - 980

JO - Journal of Medical Economics

JF - Journal of Medical Economics

SN - 1369-6998

IS - 10

M1 - 0236-RT.R1/1609300

ER -

van Mastrigt GA , Evers SM, Heerings M, Visser LH, Ruimschotel RP, Hussaarts A et al. An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability. Journal of Medical Economics. 2019 Oct 3;22(10):967-980. 0236-RT.R1/1609300. https://doi.org/10.1080/13696998.2019.1609300

Access to Document

10.1080/13696998.2019.1609300